About: Calvin A. Grant

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Calvin A. Grant Goto Sponge NotDistinct Permalink

An Entity of Type : yago:Whole100003553, within Data Space : dbpedia.org associated with source document(s)
QRcode icon

http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FCalvin_A._Grant

Calvin Alexander Grant is an American ophthalmologist. Grant was born in 1970 in Washington, D.C., to Jamaican parents, and spent a large amount of his childhood in the Washington Metropolitan Area. At the age of 21 he attended the University of Pennsylvania School of Medicine where he received the for ophthalmological research. His earlier research in gene transfer to the retina using adeno-associated viruses was one of the first. This work was conducted under the Howard Hughes Medical Student Fellowship. Grant has also become the first to introduce in the treatment of choroidal melanoma.

Attributes	Values
rdf:type	person yago:WikicatAmericanOphthalmologists yago:WikicatAmericanPeopleOfJamaicanDescent yago:WikicatLivingPeople yago:Adult109605289 yago:CausalAgent100007347 yago:Doctor110020890 yago:HealthProfessional110165109 yago:LivingThing100004258 yago:MedicalPractitioner110305802 yago:Object100002684 yago:Ophthalmologist110379073 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:Professional110480253 yago:YagoLegalActor yago:YagoLegalActorGeo yago:Specialist110632576 yago:Whole100003553
rdfs:label	Calvin A. Grant (en)
rdfs:comment	Calvin Alexander Grant is an American ophthalmologist. Grant was born in 1970 in Washington, D.C., to Jamaican parents, and spent a large amount of his childhood in the Washington Metropolitan Area. At the age of 21 he attended the University of Pennsylvania School of Medicine where he received the for ophthalmological research. His earlier research in gene transfer to the retina using adeno-associated viruses was one of the first. This work was conducted under the Howard Hughes Medical Student Fellowship. Grant has also become the first to introduce in the treatment of choroidal melanoma. (en)
dcterms:subject	1970 births Living people American ophthalmologists Perelman School of Medicine at the University of Pennsylvania alumni American people of Jamaican descent
Wikipage page ID	17397598 (xsd:integer)
Wikipage revision ID	1068840370 (xsd:integer)
Link from a Wikipage to another Wikipage	Retina Viruses 1970 births Living people American ophthalmologists Perelman School of Medicine at the University of Pennsylvania alumni Bromfenac American people of Jamaican descent Washington, D.C. Central retinal vein occlusion Jamaica Ophthalmologist University of Pennsylvania School of Medicine Ischaemic Washington Metropolitan Area Choroidal melanoma Gene transfer Adeno dbr:Oliver_prize dbr:Robotic_radiosurgery
sameAs	Calvin A. Grant Calvin A. Grant Calvin A. Grant Calvin A. Grant
dbp:wikiPageUsesTemplate	dbt:BLP_sources dbt:Citation_needed dbt:Multiple_issues dbt:Reflist dbt:Unreliable_source%3F dbt:BLP_self-published
has abstract	Calvin Alexander Grant is an American ophthalmologist. Grant was born in 1970 in Washington, D.C., to Jamaican parents, and spent a large amount of his childhood in the Washington Metropolitan Area. At the age of 21 he attended the University of Pennsylvania School of Medicine where he received the for ophthalmological research. His earlier research in gene transfer to the retina using adeno-associated viruses was one of the first. This work was conducted under the Howard Hughes Medical Student Fellowship. Grant developed the first sustained treatment for ischaemic and non-ischaemic central retinal vein occlusion. His procedure, called revascularization by anastomotic decompression (RAD), allowed for communication between the blocked superficial retinal venous circulation and the open underlying choroidal circulation. In a press release issued by ISTA Pharmaceuticals, which has a strong interest in the success of the drug, it was claimed that Grant demonstrated a significant decrease in the number of treatments of ranibizumab (Lucentis) needed for the treatment of choroidal neovascularization secondary to age-related macular degeneration by the concomitant administration of bromfenac (Xibrom). There was a significant reduction in the number of injections of ranibizumab given to those patients also receiving bromfenac during a six-month period.ISTA Pharmaceuticals at first claimed that there was no statistically significant visual acuity improvement amongst those receiving bromfenac in addition to ranibizumab, however; they now claim that upon "rigorous review" a significant improvement can be detected. ISTA Pharmaceuticals states that these results will need to be verified in clinical studies and that bromfenac is not currently approved for the treatment of age-related macular degeneration. Grant has also become the first to introduce in the treatment of choroidal melanoma. (en)
gold:hypernym	Grant
prov:wasDerivedFrom	wikipedia-en:Calvin_A._Grant?oldid=1068840370&ns=0
page length (characters) of wiki page	3284 (xsd:nonNegativeInteger)
foaf:isPrimaryTopicOf	wikipedia-en:Calvin_A._Grant
is Link from a Wikipage to another Wikipage of	Ista Grant (surname) Calvin Alexander Grant Calvin a. grant, md
is Wikipage redirect of	Calvin Alexander Grant Calvin a. grant, md
is foaf:primaryTopic of	wikipedia-en:Calvin_A._Grant

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 60 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software